Cytokinetics

Cardiovascular Account Specialist - U.S. Sales, Portland, ME

Remote

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Position Overview

  • Location Type: Territory (Lewiston, ME & Bangor, ME)
  • Employment Type: Full-time
  • Salary: Not specified
  • Company: Cytokinetics

Cytokinetics is a late-stage, specialty cardiovascular biopharmaceutical company focused on developing muscle activators and inhibitors for debilitating diseases. The company is seeking a Cardiovascular Account Specialist to drive the launch of its first commercial product, a novel cardiac myosin inhibitor for Hypertrophic Cardiomyopathy (HCM), within a designated territory. This role requires building strategic relationships with Integrated Delivery Networks (IDNs), hospitals, cardiology clinics, and specialty pharmacies, and establishing yourself as a key resource for customers. Success in this role will be driven by the company’s core values: Patients are our North Star, Science is in our Soul, We > Me, and Make it Happen.

Requirements

  • Education: Bachelor’s Degree required.
  • Experience:
    • 5+ years of experience in biotech/pharma sales.
    • Experience as a representative with sole ownership of the territory is highly preferred.
  • Preferred Experience:
    • Cardiology, rare disease, or specialty product experience.
    • Specialty product launch experience.

Responsibilities

  • Deliver sales results and operate autonomously within the territory.
  • Develop territory-specific account plans to identify and prioritize opportunities.
  • Work synergistically with internal stakeholders (medical, payer, patient navigation/support) and external customers.
  • Serve as a subject matter expert and resource to customers, providing clinically relevant disease and product information.
  • Communicate approved resources (marketing materials, payer information, formulary coverage, patient support services, educational programs) to Healthcare Professionals (HCPs) to drive demand for the product launch.
  • Identify and develop business relationships with strategic IDNs and Hospitals, cardiology clinics, and specialty pharmacies.

Application Instructions

  • Not specified

Company Information

  • Company Name: Cytokinetics
  • Focus: Developing muscle activators and inhibitors for cardiovascular diseases.
  • Core Values:
    • Patients are our North Star
    • Science is in our Soul
    • We > Me
    • Make it Happen

Skills

Biotech
Pharma Sales
Cardiology
Rare Disease
Specialty Product Launch
Account Planning
Cross-Functional Collaboration
Clinical Disease Knowledge
Demand Generation
Customer Relationship Management

Cytokinetics

Develops drugs for muscle function disorders

About Cytokinetics

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

South San Francisco, CaliforniaHeadquarters
1998Year Founded
$58.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Risks

Increased competition could impact market share and profitability.
Potential delays in clinical trials could hinder drug commercialization.
Dependence on strategic partnerships may expose Cytokinetics to risks if challenges arise.

Differentiation

Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.
The company has a robust pipeline including omecamtiv mecarbil and aficamten.
Cytokinetics engages in strategic partnerships, like with Sanofi, to expand market reach.

Upsides

Recent investments indicate strong interest in muscle activators and inhibitors.
Strategic partnerships, like with Sanofi, expand market reach and potential revenue.
Significant funding from Royalty Pharma supports commercial launch and R&D advancements.

Land your dream remote job 3x faster with AI